Announcement of the change of research and
development officer
Date of events
2022/07/01
To which item it meets
paragraph 8
Statement
1.Type of personnel changed (please enter:
spokesperson, acting spokesperson, important
personnel (CEO, COO, CMO, CSO, etc.), financial
officer, accounting officer, corporate governance
officer, research and development officer, internal
audit officer, or designated and non-designated
representatives):Research and development officer
2.Date of occurrence of the change:2022/07/01
3.Name, title, and resume of the previous position holder:
Chun-Tzer, Tsai/ director of Syn-Tech
4.Name, title, and resume of the new position holder:
Chun-Cheng, Hung/ synthesis department manager of SCP
5.Type of change (please enter: "resignation",
"position adjustment", "dismissal", "retirement",
"death" or "new replacement"):New replacement
6.Reason for the change:New replacement
7.Effective date:2022/07/01
8.Any other matters that need to be specified:
The announcement will be made after the appointment of the board.
Attachments
Original Link
Original Document
Permalink
Disclaimer
SYN-Tech Chem & Pharm Co. Ltd. published this content on 01 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 July 2022 06:52:03 UTC.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.
SYN-TECH CHEM. & PHARM. CO., LTD. 
